Nuclear Factor κB (NF-κB)-Mediated Inflammation in Multiple Sclerosis

Area of Science:

• Immunology and Neuroscience

Background:

• The nuclear factor kappa B (NF-κB) pathway regulates critical cellular processes including inflammation, proliferation, differentiation, and apoptosis.
• Dysregulation of NF-κB signaling is implicated in numerous human autoimmune and inflammatory conditions.
• Multiple sclerosis (MS) is a prototypical inflammatory demyelinating disease of the central nervous system.

Purpose of the Study:

• This review elucidates the role of aberrant NF-κB activation in the pathogenesis of multiple sclerosis.
• The study aims to identify potential therapeutic targets within the NF-κB pathway for MS treatment.

Main Methods:

• Literature review and synthesis of existing research on NF-κB signaling in the context of multiple sclerosis.
• Analysis of the molecular mechanisms linking NF-κB dysregulation to CNS inflammation and demyelination.

Main Results:

• Aberrant NF-κB activation is a key contributor to the inflammatory processes underlying multiple sclerosis.
• Specific components of the NF-κB pathway represent promising targets for novel therapeutic strategies.

Conclusions:

• Targeting the nuclear factor kappa B (NF-κB) pathway offers a viable therapeutic avenue for managing multiple sclerosis.
• Further research into NF-κB modulation could lead to effective treatments for this debilitating neurological disorder.